Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Mediated Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02273960
What this trial is testing

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Bristol-Myers Squibb 46
Large-scale testing (Phase 3)Study completedNCT00344149
What this trial is testing

Rituximab as Second Line Treatment for ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Ostfold Hospital Trust 112
Not applicableStudy completedNCT07805408
What this trial is testing

A Real World Study of Treatment Patterns and Effectiveness of Standard of Care in Primary Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia
Novartis Pharmaceuticals 3,714
Testing effectiveness (Phase 2)Study completedNCT03830749
What this trial is testing

Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Humanity & Health Medical Group Limited 53
Testing effectiveness (Phase 2)UnknownNCT05459649
What this trial is testing

Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 253
Not applicableNot Yet RecruitingNCT07662525
What this trial is testing

Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Peking University People's Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07297563
What this trial is testing

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Not applicableStudy completedNCT02063763
What this trial is testing

TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.

Who this might be right for
Adult PatientsImmune Primary ThrombocytopeniaSplenectomy+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 31
Large-scale testing (Phase 3)Study completedNCT01621204
What this trial is testing

A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenic Purpura
McMaster University 74
Not applicableLooking for participantsNCT07068126
What this trial is testing

Management of Children With Persistent ITP, A Novel Approach

Who this might be right for
Persistent Immune Thrombocytopenia
Assiut University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06838962
What this trial is testing

Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableStudy completedNCT04014166
What this trial is testing

Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

Who this might be right for
ThrombocytopeniaMesenchymal Stem Cells
Institute of Hematology & Blood Diseases Hospital, China 18
Large-scale testing (Phase 3)UnknownNCT05685420
What this trial is testing

Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 117
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738822
What this trial is testing

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Who this might be right for
Immune Thrombocytopenia (ITP)Warm Autoimmune Hemolytic Anemia (WAIHA)
Cullinan Therapeutics Inc. 72
Early research (Phase 1)Study completedNCT00001630
What this trial is testing

Treatment of Autoimmune Thrombocytopenia (AITP)

Who this might be right for
Autoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 29
Early research (Phase 1)Looking for participantsNCT06880081
What this trial is testing

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Chongqing Peg-Bio Biopharm Co., Ltd. 12
Testing effectiveness (Phase 2)UnknownNCT05943691
What this trial is testing

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Who this might be right for
ITP - Immune Thrombocytopenia
Shandong University 100
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Testing effectiveness (Phase 2)Looking for participantsNCT07294365
What this trial is testing

DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

Who this might be right for
Immune Thrombocytopenia (ITP)
Dizal Pharmaceuticals 60
Post-approval studies (Phase 4)Study completedNCT05583838
What this trial is testing

Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

Who this might be right for
Previously Treated Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 157
Next Page